Eltrombopag 25mg Tablets: For Patients with Low Platelet Counts

Eltromag 25 Tablets contain Eltrombopag, a medication that stimulates the production of platelets in patients with thrombocytopenia (low platelet count). This condition can lead to increased bleeding risks. Eltromag helps restore normal platelet levels and reduce bleeding episodes by stimulating healthy platelet production in the bone marrow.

How it works:
Eltrombopag acts on a specific receptor on cells in the bone marrow to promote megakaryocyte growth, which are responsible for producing platelets. This leads to an increase in the number of circulating platelets, enhancing clotting abilities and reducing bleeding risk.

Dosage: Eltromag 25mg is taken orally once daily, with or without food. Dosage may be adjusted by a healthcare professional based on individual patient needs and monitoring platelet count levels.

Important Note: Eltrombopag can be prescribed for patients with various forms of thrombocytopenia, including those associated with chronic lymphocytic leukemia (CLL), myelodysplastic syndromes (MDS) and other conditions where platelet counts are low.

Before taking any medication, consult a healthcare professional to confirm its suitability for your individual needs.